Applied Therapeutics to Present Data on AT-007 for the Treatment of Galactosemia at the American Society of Human Genetics (ASHG) 2020 Annual Meeting Jonathan Taylor October 21, 2020
FDA Grants AT-007 Pediatric Rare Disease Designation and Orphan Designation for Treatment of PMM2-CDG Jonathan Taylor September 24, 2020
Applied Therapeutics to Present Data on AT-001 for Treatment of Diabetic Cardiomyopathy at 56th Annual Meeting of the European Association for the Study of Diabetes Jonathan Taylor September 17, 2020
Applied Therapeutics to Present at Citi and Baird Investor Conferences Jonathan Taylor September 2, 2020
